Billionaire Li Ka-Shing’s Drug Maker Hutchmed Sells $608 Million Stake In Cardiovascular Joint Venture
Li Ka-shing, a senior adviser to CK Hutchison, which controls Hutchison Healthcare. Zhang Wei/China News Service/Visual China Group via Getty Images Hutchmed, the biopharmaceutical company controlled by Hong Kong’s richest man Li Ka-shing, is selling a 45% stake in a cardiovascular joint venture for about $608 million as it seeks to increase capital and
